Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFTAZIDIME vs CELLCEPT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFTAZIDIME vs CELLCEPT: Safety Overview

Metric CEFTAZIDIME CELLCEPT
Total FAERS Reports 3,158 332
Deaths Reported 696 72
Death Rate 22.0% 21.7%
Hospitalizations 1,503 172
Average Patient Age 52.0 yrs 51.7 yrs
% Female Patients 43.3% N/A
FDA Approval Date Apr 28, 1989 N/A
Manufacturer Hospira, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A